Vyome Holdings, Inc.
HINDHealthcare|Biotechnology|US
$1.58
-0.05 (-3.07%)
DCF Value
$1.87
Tangible Book / Share
$1.00
Cash / Share
$1.12
Financials
Financial Snapshot
Market Cap
$11.1M
Enterprise Value
$3.2M
Revenue (TTM)
$129.7K
Net Income (TTM)
-$11.3M
Cash & Investments
$7.9M
Net Cash
$7.9M
Free Cash Flow (TTM)
$524.5K
Operating CF (TTM)
$524.5K
Debt/Equity
0.00
Cash Runway & Burn Rate
Company is cash-flow positive.
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Investments | $3.3M | $10.2M | $5.5M | $2.9M | $3.0M | $22.8M | $4.0M | $4.6M | $693.0K | $5.0M | $7.9M | |
| Operating Cash Flow | -$20.7M | -$24.6M | -$27.5M | -$14.2M | -$8.6M | -$15.4M | -$21.9M | -$17.0M | -$4.4M | -$3.7M | $524.5K | |
| Free Cash Flow | -$20.7M | -$24.7M | -$27.5M | -$14.2M | -$8.9M | -$15.7M | -$22.0M | -$17.0M | -$4.4M | -$3.7M | $524.5K | |
| Capital Expenditure | -$14.0K | -$137.1K | -$49.6K | -$14.0K | -$390.0K | -$352.0K | -$131.0K | -$43.0K | $0.00 | $0.00 | -$1.00 | |
| Financing Cash Flow | $16.1M | $37.8M | $33.2M | $13.7M | $11.1M | $33.3M | $3.1M | $17.6M | $677.0K | $8.7M | $3.9M |
R&D Spending
R&D (TTM)
$1.6M
R&D Intensity
1226.5%
R&D Growth vs Prior
+170.5%
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $786.7K | $1.3M | $606.7K | $15.1M | $11.3M | $13.6M | $11.2M | $8.7M | $8.0M | $319.7K | $129.7K | |
| R&D Expense | $5.2M | $5.8M | $5.7M | $3.1M | $3.5M | $2.4M | $2.5M | $2.3M | $1.8M | $588.3K | $1.6M | |
| R&D % of Revenue | 657.1% | 448.7% | 943.1% | 20.7% | 31.0% | 17.4% | 22.6% | 26.7% | 22.5% | 184.0% | 1226.5% | |
| SG&A | $18.0M | $26.0M | $19.3M | $22.1M | $15.2M | $33.2M | $31.3M | $17.9M | $9.9M | $2.4M | $2.7M |
Income Statement
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $786.7K | $1.3M | $606.7K | $15.1M | $11.3M | $13.6M | $11.2M | $8.7M | $8.0M | $319.7K | $129.7K | |
| Cost of Revenue | $431.5K | $936.4K | $164.3K | $5.8M | $5.0M | $5.3M | $4.4M | $3.1M | $2.9M | $112.9K | $69.4K | |
| Gross Profit | $355.2K | $350.8K | $442.4K | $9.3M | $6.3M | $8.3M | $6.8M | $5.5M | $5.1M | $206.8K | $60.3K | |
| R&D | $5.2M | $5.8M | $5.7M | $3.1M | $3.5M | $2.4M | $2.5M | $2.3M | $1.8M | $588.3K | $1.6M | |
| SG&A | $18.0M | $26.0M | $19.3M | $22.1M | $15.2M | $33.2M | $31.3M | $17.9M | $9.9M | $2.4M | $2.7M | |
| Operating Income | -$22.8M | -$31.4M | -$38.5M | -$24.5M | -$12.5M | -$57.9M | -$27.1M | -$14.6M | -$7.7M | -$2.7M | -$4.2M | |
| Interest Expense | $4.1M | $3.9K | $12.0K | $451.0K | $2.0M | $832.0K | $113.0K | $0.00 | $0.00 | $146.6K | $41.7K | |
| Pretax Income | -$23.4M | -$36.1M | -$38.7M | -$75.1M | -$21.8M | -$63.4M | -$46.6M | -$11.3M | -$7.1M | -$10.5M | -$11.6M | |
| Net Income | -$23.4M | -$33.8M | -$81.2M | -$74.2M | -$21.6M | -$63.1M | -$46.2M | -$11.4M | -$7.1M | -$10.3M | -$11.3M | |
| EPS (Diluted) | -10548750.00 | -4524000.00 | -4270786.00 | -1094068.00 | -503023.26 | -419004.00 | -157897.00 | -2771.94 | -345.74 | -4.75 | -29.90 | |
| EBITDA | -$19.9M | -$32.5M | -$36.7M | -$72.9M | -$18.1M | -$60.6M | -$44.3M | -$11.2M | -$6.6M | -$10.3M | -$11.5M | |
| Shares Out. (M) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 2.16 | 7.02 |
Balance Sheet
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.3M | $10.2M | $5.5M | $2.9M | $3.0M | $22.8M | $4.0M | $4.6M | $693.0K | $5.0M | $7.9M | |
| Short-Term Investments | $2.5M | $23.3M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Total Current Assets | $5.7M | $13.9M | $8.7M | $10.1M | $8.9M | $29.9M | $9.9M | $10.3M | $4.6M | $5.4M | $8.2M | |
| Total Assets | $7.0M | $88.7M | $46.3M | $39.7M | $39.7M | $52.5M | $11.3M | $10.7M | $4.8M | $6.5M | $9.2M | |
| Total Current Liabilities | $1.3M | $1.1M | $8.4M | $10.4M | $11.6M | $7.5M | $7.5M | $3.8M | $5.0M | $2.7M | $1.9M | |
| Long-Term Debt | $9.9M | $8.0M | $0.00 | $2.7M | $9.2M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Total Liabilities | $4.1M | $12.3M | $14.6M | $15.5M | $25.2M | $8.2M | $7.6M | $4.1M | $5.0M | $2.7M | $1.9M | |
| Stockholders' Equity | $2.9M | $76.4M | $31.7M | $24.1M | $14.5M | $44.3M | $3.7M | $6.7M | -$253.0K | $2.4M | $6.0M | |
| Retained Earnings | -$300.9M | -$334.8M | -$419.0M | -$493.2M | -$514.8M | -$578.0M | -$624.2M | -$635.6M | -$642.7M | -$87.6M | -$89.2M |
Cash Flow Statement
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$20.7M | -$24.6M | -$27.5M | -$14.2M | -$8.6M | -$15.4M | -$21.9M | -$17.0M | -$4.4M | -$3.7M | $524.5K | |
| Capital Expenditure | -$14.0K | -$137.1K | -$49.6K | -$14.0K | -$390.0K | -$352.0K | -$131.0K | -$43.0K | $0.00 | $0.00 | -$1.00 | |
| Free Cash Flow | -$20.7M | -$24.7M | -$27.5M | -$14.2M | -$8.9M | -$15.7M | -$22.0M | -$17.0M | -$4.4M | -$3.7M | $524.5K | |
| Investing Cash Flow | -$14.0K | -$6.4M | -$10.3M | -$2.0M | -$2.4M | $1.9M | -$92.0K | -$10.0K | $0.00 | $0.00 | $0.00 | |
| Financing Cash Flow | $16.1M | $37.8M | $33.2M | $13.7M | $11.1M | $33.3M | $3.1M | $17.6M | $677.0K | $8.7M | $3.9M | |
| Issuance of Stock | $14.5M | $6.5M | $37.7M | $478.0K | $679.0K | $42.8M | $639.0K | $17.6M | $24.0K | $7.9M | $2.9M | |
| Repurchase of Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Net Debt Issuance | $16.8M | $0.00 | $0.00 | -$200.0K | $10.4M | -$9.5M | $0.00 | $0.00 | $653.0K | $791.3K | $1.0M | |
| Stock Based Comp. | $2.3M | $4.4M | $3.1M | $2.3M | $1.3M | $12.2M | $2.1M | $766.0K | $184.0K | $6.6M | $114.1K | |
| Net Change in Cash | -$4.6M | $6.9M | -$4.6M | -$2.6M | -$11.0M | $19.8M | -$18.9M | $604.0K | -$3.8M | $4.9M | $3.7M |
Dilution Tracker
Shares outstanding grew 5026276.7% over 5 years — significant dilution
Shares Outstanding
7M
5-Year Share Growth
+5026276.7%
Stock Issuance (TTM)
$2.9M
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Out. (M) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 2.16 | 7.02 | |
| Change vs Prior % | — | — | 13.9% | 151.4% | 95.5% | 251.2% | 94.0% | 1301.7% | 402.1% | 10380.8% | 224.7% | |
| Stock Issuance | $14.5M | $6.5M | $37.7M | $478.0K | $679.0K | $42.8M | $639.0K | $17.6M | $24.0K | $7.9M | $2.9M | |
| Stock Repurchase | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Stock Based Comp. | $2.3M | $4.4M | $3.1M | $2.3M | $1.3M | $12.2M | $2.1M | $766.0K | $184.0K | $6.6M | $114.1K |
Margins & Profitability
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 45.2% | 27.3% | 72.9% | 61.7% | 55.4% | 61.4% | 60.5% | 63.9% | 63.2% | 64.7% | 46.5% | |
| Operating Margin % | -2897.8% | -2440.1% | -6353.3% | -162.1% | -110.2% | -425.6% | -240.9% | -168.7% | -96.5% | -859.2% | -3250.3% | |
| Net Margin % | -2969.6% | -2627.3% | -13375.7% | -491.8% | -191.4% | -464.3% | -411.2% | -131.2% | -89.1% | -3209.7% | -8716.8% | |
| EBITDA Margin % | -2523.4% | -2525.6% | -6051.3% | -483.4% | -160.1% | -445.7% | -394.4% | -128.8% | -83.0% | -3227.6% | -8886.4% | |
| FCF Margin % | -2627.5% | -1920.9% | -4539.2% | -94.2% | -79.1% | -115.6% | -196.0% | -195.9% | -55.3% | -1172.6% | 404.3% | |
| ROE % | -794.9% | -44.3% | -256.3% | -307.8% | -149.3% | -142.4% | -1262.3% | -170.9% | 2818.2% | -420.2% | -254.6% | |
| ROA % | -331.8% | -38.1% | -175.4% | -187.1% | -54.5% | -120.2% | -410.2% | -106.2% | -148.8% | -157.9% | -123.2% | |
| ROIC % | -397.9% | -32.8% | -73.4% | -76.8% | -38.6% | -127.3% | -679.1% | -207.3% | -1052.9% | -72.4% | -57.5% | |
| R&D / Revenue % | 657.1% | 448.7% | 943.1% | 20.7% | 31.0% | 17.4% | 22.6% | 26.7% | 22.5% | 184.0% | 1226.5% |
Growth (Year over Year)
Fiscal years. Rising share count growth means dilution.
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 169.4% | 63.6% | -52.9% | 2387.0% | -25.1% | 20.4% | -17.4% | -22.8% | -7.7% | -96.0% | |
| Gross Profit | 112.7% | -1.2% | 26.1% | 2003.2% | -32.7% | 33.3% | -18.5% | -18.4% | -8.9% | -95.9% | |
| Operating Income | 18.2% | -37.8% | -22.7% | 36.5% | 49.1% | -364.7% | 53.2% | 45.9% | 47.2% | 64.5% | |
| Net Income | 8.4% | -44.8% | -140.0% | 8.6% | 70.9% | -191.9% | 26.8% | 75.4% | 37.4% | -43.9% | |
| EPS (Diluted) | -420.7% | 57.1% | 5.6% | 74.4% | 54.0% | 16.7% | 62.3% | 98.2% | 87.5% | 98.6% | |
| Operating Cash Flow | 8.6% | -19.0% | -11.8% | 48.3% | 39.8% | -79.8% | -42.5% | 22.6% | 73.9% | 15.3% | |
| Free Cash Flow | 8.7% | -19.6% | -11.4% | 48.4% | 37.1% | -75.9% | -40.1% | 22.8% | 74.0% | 15.3% | |
| R&D Expense | -36.5% | 11.7% | -0.9% | -45.5% | 12.1% | -32.3% | 7.1% | -8.8% | -22.1% | -67.4% | |
| SG&A Expense | -9.6% | 44.5% | -25.9% | 14.6% | -31.0% | 118.2% | -5.6% | -43.0% | -44.5% | -76.2% | |
| Total Assets | -39.2% | 1159.8% | -47.8% | -14.3% | 0.1% | 32.3% | -78.6% | -4.8% | -55.3% | 35.6% | |
| Book Value / Share | -100.0% | 0.0% | -63.6% | -69.7% | -69.3% | -12.9% | -95.7% | -87.0% | -100.8% | 114.2% | |
| Debt | -88.7% | 240.0% | 1191.5% | -14.3% | 145.2% | -97.9% | -38.7% | 53.2% | 269.1% | -96.8% | |
| Diluted Shares | -100.0% | 0.0% | 13.9% | 151.4% | 95.5% | 251.2% | 94.0% | 1301.7% | 402.1% | 10380.8% |
Valuation
P/E (TTM)At Loss
P/S85.48
10Y Low / Med / High0.69 / 4.97 / 343.39
P/B1.83
10Y Low / Med / High0.89 / 3.13 / 5.79
EV/EBITDAAt Loss
EV/Revenue24.81
10Y Low / Med / High0.19 / 3.63 / 335.88
P/FCF21.14
Intrinsic Value Models (per share)
DCF Value
$1.87
Tangible Book / Share
$1.00
Net Current Assets / Share
$0.90
Graham Net-Net
$0.87
Cash / Share
$1.12
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio | -7.30 | -12.71 | -4.22 | -1.51 | -2.59 | -1.14 | -0.25 | -0.52 | -1.29 | -0.72 | -0.05 | |
| P/S Ratio | 0.00 | 343.39 | 259.80 | 2.41 | 4.97 | 5.28 | 1.02 | 0.69 | 1.15 | 23.26 | 85.48 | |
| P/B Ratio | 0.00 | 5.79 | 4.98 | 1.51 | 3.87 | 1.62 | 3.13 | 0.89 | -36.35 | 3.04 | 1.83 | |
| EV/EBITDA | 0.16 | -13.30 | -4.31 | -0.53 | -3.67 | -0.81 | -0.17 | -0.15 | -1.43 | -0.24 | -0.28 | |
| EV/Revenue | -4.03 | 335.88 | 261.06 | 2.57 | 5.87 | 3.63 | 0.68 | 0.19 | 1.18 | 7.77 | 24.81 |
Analyst Estimates & Quality
Altman Z-Score
-13.36
Distress
Piotroski F-Score
3
Weak
Forward Estimates (consensus)
| Metric | FY2026 | FY2027 | FY2028 |
|---|---|---|---|
| Revenue | $69.7K | $250.0K | $17.0M |
| Net Income | -$1.4M | -$1.8M | -$1.7M |
| EPS | $-0.65 | $-0.84 | $-0.80 |
| # Analysts (EPS) | 2 | 2 | 2 |
Revenue Segments
By Product
| Segment | 2018 | 2025 |
|---|---|---|
| Product | $606.7K | $174.6K |
| License | — | $116.9K |
| Royalty | — | $28.2K |
By Geography
| Segment | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Non Us | $1.8M | $114.0K | — | — | — | — |
| U | $13.3M | $8.3M | — | — | — | — |
| Europe | — | $1.8M | $2.1M | $1.3M | $956.0K | $687.0K |
| Australia | — | — | $1.0M | $688.0K | $526.0K | — |
| Rest of world | — | — | $137.0K | $70.0K | $62.0K | — |
| United States | — | — | $10.3M | $9.2M | $7.1M | — |
| AUSTRALIA | — | — | — | — | — | $392.0K |
| Non-US | — | — | — | — | — | $40.0K |
| UNITED STATES | — | — | — | — | — | $6.9M |